
Precigen
(NASDAQ) PGEN
Precigen Financials at a Glance
Market Cap
$1.90BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$31.60M
Net Income (TTM)
-$204.42M
EPS (TTM)
-$1.24
P/E Ratio
-4.30
Dividend
$0.00
Beta (Volatility)
1.80 (High)
Dividend
$0.00
Beta (Volatility)
1.80 (High)
Price
$5.35
Volume
3,455,433.559
Open
$5.50
Price
$5.35
Volume
3,455,433.559
Open
$5.50
Previous Close
$5.32
Daily Range
$5.17 - $5.50
52-Week Range
$1.47 - $6.04
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
1.80 (High)
Price
$5.35
Volume
3,455,433.559
Open
$5.50
Previous Close
$5.32
Daily Range
$5.17 - $5.50
52-Week Range
$1.47 - $6.04
Estimated Earnings Date
Aug 11, 2026
PGEN News
PGEN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Precigen
Industry
Biotechnology
Sector
Health CareEmployees
160
CEO
Helen Sabzevari, PhD
Website
www.precigen.comHeadquarters
Germantown, MD 20876, US
PGEN Financials
Key Financial Metrics (TTM)
Gross Margin
75.63%
Operating Margin
-297.21%
Net Income Margin
-646.99%
Return on Equity
-1768.51%
Return on Capital
-89.43%
Return on Assets
-147.46%
Earnings Yield
-23.26%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.90BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
356.51M
Volume
3.46M
Avg. Volume
4.46M
Financials (TTM)
Gross Profit
$23.90M
Operating Income
-$93.91M
EBITDA
-$195.19M
Operating Cash Flow
-$115.33M
Capital Expenditure
-$2.24M
Free Cash Flow
-$117.57M
Cash & ST Invst.
$56.25M
Total Debt
$98.25M
Precigen Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$23.25M
+1633.9%
Gross Profit
$20.38M
+26221.8%
Gross Margin
87.63%
N/A
Market Cap
$1.90BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$13.26M
N/A
Employees
143
N/A
Net Income
-$7.93M
+85.4%
EBITDA
-$3.92M
+92.7%
Quarterly Fundamentals
Total Cash
$56.25M
-29.9%
Total Debt
$98.25M
+1713.7%
Accounts Receivable
$26.71M
+2409.9%
Inventory
$14.73M
N/A
Long Term Debt
$97.18M
+2064.9%
Short Term Debt
$1.07M
+15.1%
Return on Assets
-1.47%
N/A
Return on Invested Capital
-79.90%
N/A
Free Cash Flow
-$44.09M
-160.1%
Operating Cash Flow
-$43.83M
-168.5%







